BRPI0614099B8 - uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto e o referido composto - Google Patents
uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto e o referido compostoInfo
- Publication number
- BRPI0614099B8 BRPI0614099B8 BRPI0614099A BRPI0614099A BRPI0614099B8 BR PI0614099 B8 BRPI0614099 B8 BR PI0614099B8 BR PI0614099 A BRPI0614099 A BR PI0614099A BR PI0614099 A BRPI0614099 A BR PI0614099A BR PI0614099 B8 BRPI0614099 B8 BR PI0614099B8
- Authority
- BR
- Brazil
- Prior art keywords
- alkyl
- compound
- hydrogen
- combination
- het
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05107155 | 2005-08-03 | ||
| EP05107155.3 | 2005-08-03 | ||
| PCT/EP2006/064847 WO2007014934A2 (en) | 2005-08-03 | 2006-07-31 | Quinoline derivatives as antibacterial agents |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI0614099A2 BRPI0614099A2 (pt) | 2011-03-09 |
| BRPI0614099B1 BRPI0614099B1 (pt) | 2019-11-12 |
| BRPI0614099B8 true BRPI0614099B8 (pt) | 2021-05-25 |
Family
ID=35768115
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0614099A BRPI0614099B8 (pt) | 2005-08-03 | 2006-07-31 | uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto e o referido composto |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US8691800B2 (enExample) |
| EP (1) | EP1912649B1 (enExample) |
| JP (1) | JP5208739B2 (enExample) |
| KR (1) | KR101413094B1 (enExample) |
| CN (1) | CN101277698B (enExample) |
| AP (1) | AP2483A (enExample) |
| AR (1) | AR054888A1 (enExample) |
| AU (1) | AU2006274873B2 (enExample) |
| BR (1) | BRPI0614099B8 (enExample) |
| CA (1) | CA2615900C (enExample) |
| CY (1) | CY1113535T1 (enExample) |
| DK (1) | DK1912649T3 (enExample) |
| EA (1) | EA014834B1 (enExample) |
| ES (1) | ES2397358T3 (enExample) |
| HR (1) | HRP20120910T1 (enExample) |
| IL (1) | IL189140A (enExample) |
| JO (1) | JO2837B1 (enExample) |
| ME (1) | ME01485B (enExample) |
| MX (1) | MX2008001601A (enExample) |
| MY (1) | MY147637A (enExample) |
| NO (1) | NO342328B1 (enExample) |
| NZ (1) | NZ566012A (enExample) |
| PL (1) | PL1912649T3 (enExample) |
| PT (1) | PT1912649E (enExample) |
| RS (1) | RS52606B (enExample) |
| SI (1) | SI1912649T1 (enExample) |
| TW (1) | TWI385168B (enExample) |
| UA (1) | UA95911C2 (enExample) |
| WO (1) | WO2007014934A2 (enExample) |
| ZA (1) | ZA200801106B (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JO2837B1 (en) | 2005-08-03 | 2014-09-15 | جانسن فارمسيتكا ان في | Quinoline derivatives acting as antibacterial agents |
| JO3271B1 (ar) * | 2006-12-06 | 2018-09-16 | Janssen Pharmaceutica Nv | مشتقات الكوينولين المضادة للجراثيم |
| JO2683B1 (en) * | 2006-12-06 | 2013-03-03 | جانسين فارماسوتيكا ان. في | Quinoline antibacterial derivatives |
| JP5246715B2 (ja) * | 2009-01-27 | 2013-07-24 | 独立行政法人科学技術振興機構 | 蛋白質架橋阻害剤およびその用途 |
| CN104254528B (zh) | 2012-04-27 | 2017-06-06 | 詹森药业有限公司 | 抗菌的喹啉衍生物 |
| US9133167B2 (en) | 2012-04-27 | 2015-09-15 | Janssen Pharmaceutica Nv | Antibacterial quinoline derivatives |
| EA201891644A1 (ru) * | 2016-03-07 | 2019-04-30 | Зе Глобал Эллайенс Фо Тб Драг Девелопмент, Инк. | Антибактериальные соединения и их применение |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001503411A (ja) * | 1996-10-28 | 2001-03-13 | ディパートメント オブ ジ アーミー，ユー．エス．ガバメント | 抗生物質耐性感染症の処置のための化合物、組成物および方法 |
| US6103905A (en) * | 1997-06-19 | 2000-08-15 | Sepracor, Inc. | Quinoline-indole antimicrobial agents, uses and compositions related thereto |
| GB0101577D0 (en) * | 2001-01-22 | 2001-03-07 | Smithkline Beecham Plc | Compounds |
| AR040336A1 (es) * | 2002-06-26 | 2005-03-30 | Glaxo Group Ltd | Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto |
| RS52431B (sr) * | 2002-07-25 | 2013-02-28 | Janssen Pharmaceutica N.V. | Derivati hinolina i njihova upotreba kao mikobakterijskih inhibitora |
| EP1711492B1 (en) * | 2004-01-23 | 2008-04-16 | Janssen Pharmaceutica N.V. | Substituted quinolines and their use as mycobacterial inhibitors |
| JO2837B1 (en) | 2005-08-03 | 2014-09-15 | جانسن فارمسيتكا ان في | Quinoline derivatives acting as antibacterial agents |
-
2006
- 2006-07-18 JO JO2006234A patent/JO2837B1/en active
- 2006-07-31 CN CN2006800367813A patent/CN101277698B/zh active Active
- 2006-07-31 PL PL06792614T patent/PL1912649T3/pl unknown
- 2006-07-31 PT PT67926147T patent/PT1912649E/pt unknown
- 2006-07-31 SI SI200631469T patent/SI1912649T1/sl unknown
- 2006-07-31 JP JP2008524502A patent/JP5208739B2/ja not_active Expired - Fee Related
- 2006-07-31 MX MX2008001601A patent/MX2008001601A/es active IP Right Grant
- 2006-07-31 US US11/997,015 patent/US8691800B2/en active Active
- 2006-07-31 EP EP06792614A patent/EP1912649B1/en active Active
- 2006-07-31 NZ NZ566012A patent/NZ566012A/en unknown
- 2006-07-31 WO PCT/EP2006/064847 patent/WO2007014934A2/en not_active Ceased
- 2006-07-31 CA CA2615900A patent/CA2615900C/en active Active
- 2006-07-31 DK DK06792614.7T patent/DK1912649T3/da active
- 2006-07-31 ME MEP-2012-146A patent/ME01485B/me unknown
- 2006-07-31 UA UAA200800827A patent/UA95911C2/ru unknown
- 2006-07-31 ES ES06792614T patent/ES2397358T3/es active Active
- 2006-07-31 BR BRPI0614099A patent/BRPI0614099B8/pt active IP Right Grant
- 2006-07-31 EA EA200800513A patent/EA014834B1/ru unknown
- 2006-07-31 AU AU2006274873A patent/AU2006274873B2/en active Active
- 2006-07-31 HR HRP20120910TT patent/HRP20120910T1/hr unknown
- 2006-07-31 KR KR1020087005063A patent/KR101413094B1/ko active Active
- 2006-07-31 RS RS20120577A patent/RS52606B/sr unknown
- 2006-07-31 AP AP2008004320A patent/AP2483A/xx active
- 2006-08-01 MY MYPI20063725A patent/MY147637A/en unknown
- 2006-08-02 AR ARP060103370A patent/AR054888A1/es unknown
- 2006-08-02 TW TW095128222A patent/TWI385168B/zh not_active IP Right Cessation
-
2008
- 2008-01-31 IL IL189140A patent/IL189140A/en active IP Right Grant
- 2008-02-01 ZA ZA200801106A patent/ZA200801106B/xx unknown
- 2008-02-29 NO NO20081068A patent/NO342328B1/no unknown
-
2013
- 2013-01-08 CY CY20131100015T patent/CY1113535T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0614524B8 (pt) | uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto, e o referido composto | |
| BRPI0506400A8 (pt) | Uso de um composto para a fabricação de um medicamento para o tratamento de tuberculose latente | |
| BRPI0614493B8 (pt) | uso de um composto derivado de quinolina, sua combinação, composição farmacêutica, uso da referida combinação, produto, processo para a preparação de um composto e o referido composto | |
| PE20090216A1 (es) | Compuestos triazolil aminopirimidina | |
| CY1113535T1 (el) | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες | |
| BRPI0507076B8 (pt) | quinolinas substituídas, seu processo de preparação, composição farmacêutica que as compreende e seu uso como inibidores micobacterianos | |
| CY1113579T1 (el) | Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες | |
| MY173664A (en) | Quinoline derivatives as antibacterial agents | |
| MY151030A (en) | Quinoline derivatives as antibacterial agents |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/11/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/11/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/07/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |